Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

In this review article we discuss the role of the memory T cells in multiple myeloma (MM) and how they may influence immune responses in patients that received immunomodulating drugs and check point therapy.

Detalles Bibliográficos
Autores principales: Sponaas, Anne Marit, Waage, Anders, Vandsemb, Esten N., Misund, Kristine, Børset, Magne, Sundan, Anders, Slørdahl, Tobias Schmidt, Standal, Therese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928324/
https://www.ncbi.nlm.nih.gov/pubmed/33679794
http://dx.doi.org/10.3389/fimmu.2021.636375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928324/
https://www.ncbi.nlm.nih.gov/pubmed/33679794
http://dx.doi.org/10.3389/fimmu.2021.636375

Ejemplares similares